TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01088165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02715882 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01304069 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00616213 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01091142 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00400556 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01302223 — Predictive Biomarker (PRD): FGF7 mRNA
Genes: FGF7; KGF
Study NCT01302223 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01302223 — Safety Biomarker (SAF): Interleukin 1
Study NCT02406690 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01637636 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02310685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00690014 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02899507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00001650 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01005316 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT00370760 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT00574730 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT00163943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01022957 — Predictive Biomarker (PRD): NPHP1 mRNA
Genes: NPHP1; NPH1
Study NCT01022957 — Predictive Biomarker (PRD): INVS mRNA
Genes: INVS; INV; NPHP2
Study NCT01022957 — Predictive Biomarker (PRD): NPHP3 mRNA
Genes: NPHP3; KIAA2000
Study NCT01022957 — Predictive Biomarker (PRD): NPHP4 mRNA
Genes: NPHP4; KIAA0673
Study NCT01022957 — Predictive Biomarker (PRD): IQCB1 mRNA
Genes: IQCB1; KIAA0036; NPHP5; OK/SW-cl.85
Study NCT01022957 — Predictive Biomarker (PRD): CEP290 mRNA
Genes: CEP290; BBS14; KIAA0373; NPHP6
Study NCT01022957 — Predictive Biomarker (PRD): RPGRIP1L mRNA
Genes: RPGRIP1L; FTM; KIAA1005; NPHP8
Study NCT01175486 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00695955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03661424 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01311128 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03065621 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03065621 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01631747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01631747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01631747 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03295383 — Predictive Biomarker (PRD): COL17A1 mRNA
Genes: COL17A1; BP180; BPAG2
Study NCT03505723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00460278 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00642434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03326401 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01168791 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT06159933 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT01011491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03822312 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03280303 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04261972 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03398434 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05697666 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT02261714 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02534558 — Monitoring Biomarker (MOI): miR-29a
Genes: MIR29A
Study NCT06608953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04193085 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03225118 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00785109 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT00785109 — Predictive Biomarker (PRD): MPG mRNA
Genes: MPG; AAG; ANPG; MID1
Study NCT01838330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01838330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01838330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03392389 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01261442 — Predictive Biomarker (PRD): PTN mRNA
Genes: PTN; HBNF1; NEGF1
Study NCT04027049 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04027049 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04027049 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04027049 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00001250 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00001250 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03673787 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02654288 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02631174 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT03058185 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT03058185 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT03165240 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01530035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01707433 — Predictive Biomarker (PRD): ARSB mRNA
Genes: ARSB
Study NCT03114579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01327079 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT00063895 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00155727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00470093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00558948 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01950793 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05384418 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01032291 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00396006 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03739736 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04547907 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01940250 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02135029 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04266249 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03941457 — Predictive Biomarker (PRD): ROBO1 mRNA
Genes: ROBO1; DUTT1
Study NCT00531557 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02382029 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT03292055 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03292055 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02080897 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01893554 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04127786 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01028534 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04676841 — Surrogate Endpoint (SUR): Bacterial count
Study NCT02154100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02154100 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02154100 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02480491 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01316757 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00448851 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT03614481 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00704483 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00350272 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00908869 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00364572 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01118520 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01865812 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03073018 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01636505 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT02319161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04025502 — Pharmacodynamic Biomarker (PDY): Auditory steady-state response
Study NCT04290793 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04376684 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03440736 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03440736 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03785249 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00372372 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02519894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03932422 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00491387 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00491387 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01225575 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00159250 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00654407 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02344680 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00390325 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT02419742 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04712890 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04712890 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04712890 — Predictive Biomarker (PRD): BARD1 mRNA
Genes: BARD1
Study NCT04712890 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT04712890 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT04712890 — Predictive Biomarker (PRD): FANCL mRNA
Genes: FANCL; PHF9
Study NCT04712890 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT04712890 — Predictive Biomarker (PRD): PPP2R2A mRNA
Genes: PPP2R2A
Study NCT04712890 — Predictive Biomarker (PRD): RAD51B mRNA
Genes: RAD51B; RAD51L1; REC2
Study NCT04712890 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study NCT00843583 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02581956 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01610440 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01610440 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01054781 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03830060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00070187 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00070187 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00520975 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00520975 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01524848 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01524848 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT01524848 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01555268 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01653496 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT01016444 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT01180673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04660825 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03031808 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02598427 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01774786 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03978260 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04996459 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT04996459 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT02157155 — Predictive Biomarker (PRD): PNPLA2 mRNA
Genes: PNPLA2; ATGL; FP17548
Study NCT03099876 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01492322 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT02694406 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02872896 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02419404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04839094 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04246606 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00977132 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01522768 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01964274 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Cholinesterase
Genes: BCHE; CHE1
Study NCT02363725 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00819338 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00657241 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01802658 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02916615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00118976 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01393405 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT00708942 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT00708942 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02659527 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02659527 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03303404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03900000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01237873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00616265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03632187 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03632187 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03632187 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT00745992 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01535196 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03862274 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT02034786 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06301893 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06301893 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT00661076 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02799758 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02285101 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study NCT03689998 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03689998 — Safety Biomarker (SAF): Interleukin 1
Study NCT04283006 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04283006 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02778412 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04702204 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03592147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00113152 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01224847 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04586946 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03154554 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT05024500 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03163888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01374685 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04130243 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00727753 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02748213 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03758196 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002504 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02130661 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT00641407 — Predictive Biomarker (PRD): NPL mRNA
Genes: NPL; C1orf13
Study NCT03359642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00659256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00361179 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00323492 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00323492 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03828812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02374645 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02374645 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03143699 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01648855 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01648855 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03830944 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04863755 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03630809 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01386736 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05525156 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02191228 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05200754 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01712256 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00169143 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00590109 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00590109 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT01772303 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01132482 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00696514 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02684643 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT01441674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02631863 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04294511 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02771483 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT04254978 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT02270164 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01237158 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01147861 — Predictive Biomarker (PRD): HCAR2 mRNA
Genes: HCAR2; GPR109A; HCA2; HM74A; NIACR1
Study NCT03406858 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02881242 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT03832621 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03832621 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT03832621 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT03832621 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT03832621 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03936361 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01759108 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT02808130 — Predictive Biomarker (PRD): PC mRNA
Genes: PC